Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 11/20 | 0.56 |
| ▸ | CYSLTR2 | Q9NS75 | 8/20 | 0.56 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.47 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8541189 | 0.90 | AKR1B1 (0.57) | CYSLTR1CYSLTR2GPBAR1ALOX5AKR1B1 | |
| SCHEMBL8540638 | 0.80 | ALOX5 (0.50) | CYSLTR1CYSLTR2GPBAR1ALOX5AKR1B1 | |
| SCHEMBL9053241 | 0.77 | CYSLTR1 (0.73) | CYSLTR1CYSLTR2GPBAR1ALOX5AKR1B1 | |
| SCHEMBL8543204 | 0.77 | FFAR1 (0.57) | CYSLTR1CYSLTR2GPBAR1ALOX5AKR1B1 | |
| SCHEMBL9140671 | 0.75 | LTB4R (0.57) | CYSLTR1CYSLTR2ALOX5AKR1B1FFAR1 | |
| SCHEMBL9656045 | 0.75 | CYSLTR1 (0.85) | CYSLTR1CYSLTR2GPBAR1ALOX5AKR1B1 | |
| SCHEMBL6088484 | 0.74 | CYSLTR1 (0.69) | CYSLTR1CYSLTR2GPBAR1ALOX5 | |
| SCHEMBL9701519 | 0.74 | KMT2A (0.60) | ALOX5AKR1B1AKR1A1 | |
| SCHEMBL8538426 | 0.73 | CYSLTR1 (0.65) | CYSLTR1CYSLTR2GPBAR1ALOX5 | |
| SCHEMBL7716691 | 0.73 | CYSLTR1 (0.88) | CYSLTR1CYSLTR2GPBAR1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7005440-B1 | Therapeutic uses of tri-aryl acid derivatives | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2006-02-28 | — | — | US | disclosed |
| EP-1177176-A1 | TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | Aventis Pharma Deutschland GmbH (DE) | 2002-02-06 | — | — | EP | disclosed |
| WO-2000064876-A1 | TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-11-02 | — | — | WO | disclosed |